Your browser doesn't support javascript.
loading
MiR-16-1-3p and miR-16-2-3p possess strong tumor suppressive and antimetastatic properties in osteosarcoma.
Maximov, Vadim V; Akkawi, Rania; Khawaled, Saleh; Salah, Zaidoun; Jaber, Lina; Barhoum, Ahlam; Or, Omer; Galasso, Marco; Kurek, Kyle C; Yavin, Eylon; Aqeilan, Rami I.
Afiliação
  • Maximov VV; The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.
  • Akkawi R; The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.
  • Khawaled S; The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.
  • Salah Z; Al Quds-Bard College, Al-Quds University, Al-Bireh, East Jerusalem, Palestine.
  • Jaber L; The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.
  • Barhoum A; The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.
  • Or O; Department of Orthopedics Surgery, Hebrew University Hadassah Medical Center, Jerusalem, Israel.
  • Galasso M; Biosystems Analysis, LTTA, Department of Morphology, Surgery and Experimental Medicine, Università degli Studi, Ferrara, Italy.
  • Kurek KC; Department of Pathology and Medical Genetics Cumming School of Medicine, University of Calgary, Alberta Children's Hospital & Research Institute, Calgary, AB, Canada.
  • Yavin E; The Institute for Drug Research, The School of Pharmacy, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Aqeilan RI; The Lautenberg Center for General and Tumor Immunology, Department of Immunology and Cancer Research-IMRIC, The Hebrew University-Hadassah Medical School at Ein-Kerem, Jerusalem, Israel.
Int J Cancer ; 145(11): 3052-3063, 2019 12 01.
Article em En | MEDLINE | ID: mdl-31018244
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteonecrose / Osteossarcoma / Regulação para Baixo / MicroRNAs / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteonecrose / Osteossarcoma / Regulação para Baixo / MicroRNAs / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel País de publicação: Estados Unidos